Susquehanna International Group’s Armata Pharmaceuticals ARMP Stock Holding History
Bought
Maintained
Sold
Other funds holding ARMP
MAM
VCM
6CM
DIG
VFT
Susquehanna International Group's ARMP Position: Q1 2026 in Review
Susquehanna International Group increased its Armata Pharmaceuticals (ARMP) stake by 166% in Q1 2026, buying an estimated $340K and bringing the position to 64,759 shares worth $663K. The position accounts for ﹤0.01% of the portfolio, ranked #8930.
Susquehanna International Group first reported a position in ARMP in Q1 2017 and has held it in 13 quarters since. 45 funds tracked by Wall St. Rank hold ARMP as of Q1 2026.
- Susquehanna International Group held 64,759 shares of Armata Pharmaceuticals worth $663K as of Q1 2026.
- Susquehanna International Group bought 40,399 Armata Pharmaceuticals shares in Q1 2026, an estimated $340K.
- Armata Pharmaceuticals made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #8930 holding.
- Susquehanna International Group first reported a position in Armata Pharmaceuticals in Q1 2017 and has held it in 13 quarters since.
- 45 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.